title: Prognostic value of telomerase and DNA ploidy in laryngeal carcinoma.
abstract: Prognosis of carcinoma of the larynx is currently based on the morphologic analysis of the tumor extent, differentiation grading and type of microscopic invasion. The DNA ploidy status and the cell proliferation activity may give complementary information about the prognosis. Telomerase may be used as a measure of tumor proliferation. The aim of this work was to investigate the probable application of telomerase as a measure of cell immortalization as well as DNA ploidy as a measure of cell proliferation in the prognosis of patients with laryngeal carcinoma. The work was carried out as a prospective observational study that included 35 patients with laryngeal carcinoma who were treated surgically at Ain Shams University Hospitals, Cairo, Egypt. Flowcytometric analysis and biochemical assay of telomerase using human Telomerase Reverse Transcriptase (hTERT) mRNA assay by RT-PCR in resected specimens were done. The proliferative indices in different parts of the tumor were found to be significantly different from each other, with those of tumor edges being the highest. The ploidy status at the edge of the tumor was significantly different between surviving and non-surviving patients, while the tumor core proliferative index was found to be significantly lower in patients without recurrence than those with recurrence. A gradient of telomerase levels was noticed, with levels from tumor cores being the highest followed by tumor edges, resection margins and the lowest levels in lymph nodes. Multivariate analysis showed hTERT levels in tumor edges to significantly affect survival. Both Flowcytometric parameters and telomerase activity may be useful as a prognostic factor for survival in patients with laryngeal carcinoma. Telomerase activity may be used for biologic demarcation for conservational laryngeal surgery, as well as a 'spectral' marker.
authors.affiliation: Department of Otolaryngology, Ain Shams University Faculty of Medicine, Cairo, Egypt.
authors.forename: Talaat
authors.initials: T
authors.lastname: El Samny
authors.forename: Hisham
authors.initials: H
authors.lastname: El Halaby
authors.forename: Lobna
authors.initials: L
authors.lastname: El Fiky
authors.forename: Mohamed
authors.initials: M
authors.lastname: Nassar
authors.forename: Ali
authors.initials: A
authors.lastname: El Makhzangy
authors.forename: Sannaa
authors.initials: S
authors.lastname: Eissa
mesh_terms: D000328:Adult; D000368:Aged; D049109:Cell Proliferation; D004273:DNA, Neoplasm / Q000032:analysis*; D018572:Disease-Free Survival; D005260:Female; D005434:Flow Cytometry; D006801:Humans; D007822:Laryngeal Neoplasms / Q000175:diagnosis* / Q000401:mortality / Q000473:pathology; D008297:Male; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000175:diagnosis* / Q000401:mortality / Q000473:pathology; D011003:Ploidies; D011379:Prognosis; D011446:Prospective Studies; D012333:RNA, Messenger / Q000032:analysis; D020133:Reverse Transcriptase Polymerase Chain Reaction; D019098:Telomerase / Q000032:analysis* / Q000235:genetics
chemical_list: D004273:DNA, Neoplasm; D012333:RNA, Messenger; D019098:Telomerase
references.citation: Laryngoscope. 1993 May;103(5):538-40
references.pmid: 8483372
references.citation: Cell. 1997 Aug 22;90(4):785-95
references.pmid: 9288757
references.citation: Curr Biol. 1998 Jan 29;8(3):177-80
references.pmid: 9443919
references.citation: Nature. 1984 Jul 12-18;310(5973):154-7
references.pmid: 6330571
references.citation: Arch Otolaryngol Head Neck Surg. 1998 Jul;124(7):784-8
references.pmid: 9677114
references.citation: Laryngoscope. 1993 May;103(5):498-502
references.pmid: 8483365
references.citation: Mol Med Today. 1999 Mar;5(3):114-22
references.pmid: 10203735
references.citation: Laryngoscope. 1982 Sep;92(9 Pt 1):1064-9
references.pmid: 7121161
references.citation: Laryngoscope. 2000 Mar;110(3 Pt 1):391-6
references.pmid: 10718425
references.citation: Arch Otolaryngol Head Neck Surg. 1992 Feb;118(2):169-73
references.pmid: 1540348
references.citation: Acta Otolaryngol. 1992;112(2):376-82
references.pmid: 1605011
references.citation: Anticancer Res. 2001 Nov-Dec;21(6A):4011-5
references.pmid: 11911285
references.citation: Mol Cell Biol. 1996 Jun;16(6):2932-9
references.pmid: 8649404
references.citation: Science. 1994 Dec 23;266(5193):2011-5
references.pmid: 7605428
references.citation: Am J Surg. 1986 Oct;152(4):396-402
references.pmid: 3766870
references.citation: Clin Cancer Res. 1996 Nov;2(11):1895-900
references.pmid: 9816146
references.citation: Cancer. 1991 Jan 1;67(1):141-9
references.pmid: 1985711
references.citation: Ann Otol Rhinol Laryngol. 1995 Jul;104(7):503-10
references.pmid: 7598360
references.citation: Cancer. 1998 Jun 1;82(11):2159-65
references.pmid: 9610695